 SOUTH SAN FRANCISCO, Calif., June 02, 2022 GLOBE NEWSWIRE -- Sutro Biopharma, Inc. Sutro or the Company NASDAQ: STRO, a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in two upcoming investor conferences. 